530881 — Arunjyoti Bio Ventures Income Statement
0.000.00%
- IN₹1.22bn
- IN₹1.48bn
- IN₹281.65m
Annual income statement for Arunjyoti Bio Ventures, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | ARS | PRESS |
Standards: | IAS | IAS | — | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 55.1 | 32.5 | 18.3 | 205 | 282 |
Cost of Revenue | |||||
Gross Profit | 7.01 | 3.69 | 3.35 | 119 | 229 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 54.2 | 31.7 | 15.6 | 197 | 259 |
Operating Profit | 0.938 | 0.77 | 2.66 | 7.93 | 22.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.922 | 0.76 | 2.66 | -13 | -3.41 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.683 | 0.563 | 2.22 | -3.49 | -18.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.683 | 0.563 | 2.22 | -3.49 | -18.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.683 | 0.563 | 2.22 | -3.49 | -18.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.006 | 0.005 | 0.02 | -0.168 | -0.1 |